Report Detail Page

LipiMAX lipoprotein cell culture media supplement

Selborne Biological Services (SBS) and MLA developed a lipoprotein cell culture media supplement, LipiMAX which is extracted from adult bovine blood sourced from abattoirs in Australia.

In order to demonstrate the safety of pharmaceutical proteins derived from biological sources it was mandatory for the manufacturer of such products to demonstrate the effective inactivation and/or removal of pathogenic viruses during the manufacturing process. Usually, this is done by the deliberate spiking of a down-scaled version of the manufacturing process with relevant and/or model viruses.

The purpose of study under P.PSH.0218 was to test for the effectiveness of heat treatment to inactivate viruses during the manufacturing process of a Lipoprotein. The appropriate model virus for this process is BVDV, an enveloped RNA Flavivirus.


LIPIMAX has been successfully commercialised.


Title Size Date published
217.7KB 01/06/2007


Contract No. Title Start date End date Funding type
Viral Inactivation Validation of Lipoprotein Process
28/08/2006 30/06/2007
#MDC# Selborne Lipoprotein Business Planning Project
28/10/2005 04/09/2006
#MDC A Method of Preparing Lipoprotein from a Blood Source
10/09/2002 04/09/2006

This page was last updated on 06/07/2018

Join myMLA today

One username and password for key integrity and information Systems (LPA/NVD, NLIS, MSA & LDL).

A personalised online dashboard that provides news, weather, events and R&D tools relevant to you.

Customised market information and analysis.

Learn more about myMLA

myMLA Sign Up

Already registered for myMLA?

Sign in here